Cargando…
Integrative Analysis Revealed LINC00847 as a Potential Target of Tumor Immunotherapy
Lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer-related death. Lung adenocarcinoma (LUAD) is the most common form of lung cancer and has a low 5-year survival rate. Therefore, much more research is needed to identify cancer biomarkers, promote biomarker-drive...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511587/ https://www.ncbi.nlm.nih.gov/pubmed/36864364 http://dx.doi.org/10.1007/s12010-023-04387-z |